The possible association among breast cancer, diabetes mellitus and GLP-1 receptor

被引：0
|
作者：
Takigami, Naoko [1 ]
Kuniyoshi, Shimpei [2 ]
Miki, Yasuhiko [2 ]
Tamaki, Kentaro [1 ]
Kamada, Yoshihiko [1 ]
Uehara, Kano [1 ]
Tsuchiya, Seiko [1 ]
Terukina, Shigeharu [1 ]
Ishida, Takanori [3 ]
Miyashita, Minoru [3 ]
Kanai, Ayako [3 ]
McNamara, Keely May [2 ]
Tamaki, Nobumitsu [1 ]
Sasano, Hironobu [2 ]
机构：
[1] Nahanishi Clin, Okinawa, Japan
[2] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Breast & Endcrine Surg, Sendai, Miyagi, Japan
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-02-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-02-10
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility
    Yang, Mo
    Fukui, Hirokazu
    Eda, Hirotsugu
    Xu, Xin
    Kitayama, Yoshitaka
    Hara, Ken
    Kodani, Mio
    Tomita, Toshihiko
    Oshima, Tadayuki
    Watari, Jiro
    Miwa, Hiroto
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2017, 312 (04): : G367 - G373
  • [32] Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes
    Foer, Dinah
    Strasser, Zachary H.
    Cui, Jing
    Cahill, Katherine N.
    Boyce, Joshua A.
    Murphy, Shawn N.
    Karlson, Elizabeth W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (10) : 1088 - 1100
  • [33] GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes
    Do, Duy
    Lee, Tiffany
    Peasah, Samuel K.
    Good, Chester B.
    Inneh, Angela
    Patel, Urvashi
    JAMA NETWORK OPEN, 2024, 7 (05)
  • [34] Treatment of Type 2 Diabetes With GLP-1 Receptor Agonists Among Patients With CKD
    Ostergaard, Jakob A.
    Cooper, Mark E.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2323 - 2324
  • [35] Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
    Selley, E.
    Kun, S.
    Szijarto, I. A.
    Kertesz, M.
    Wittmann, I.
    Molnar, G. A.
    HORMONE AND METABOLIC RESEARCH, 2016, 48 (07) : 476 - 483
  • [36] Gestational Diabetes Mellitus (GDM) May Reflect GLP-1 Resistance
    Hone, Jennifer
    Pettitt, David J.
    Trujillo, Angelina L.
    Zisser, Howard
    Wollitzer, Alison Okada
    Jovanovic, Lois
    DIABETES, 2010, 59 : A3 - A3
  • [37] IN TYPE 2 DIABETES MELLITUS THE GLP-1 EFFECTS ON PLATELETS ARE IMPAIRED
    Barale, C.
    Frascaroli, C.
    Cavalot, F.
    Guerrasio, A.
    Russo, I.
    ATHEROSCLEROSIS, 2016, 252 : E257 - E258
  • [38] Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus
    Bonde, L.
    Vilsboll, T.
    Nielsen, T.
    Bagger, J. I.
    Svare, J. A.
    Holst, J. J.
    Larsen, S.
    Knop, F. K.
    DIABETES OBESITY & METABOLISM, 2013, 15 (08): : 713 - 720
  • [39] Awareness of use of GLP-1 agonists in the treatment of Diabetes Mellitus in Pakistan
    Baig, Muhammad Usman
    Farooq, Muhammad Ahmad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (08) : 1769 - 1769
  • [40] Aerosolized GLP-1 for Treatment of Diabetes Mellitus and Irritable Bowel Syndrome
    Siekmeier, Ruediger
    Hofmann, Thomas
    Scheuch, Gerhard
    Pokorski, Mieczyslaw
    ENVIRONMENTAL BIOMEDICINE, 2015, 849 : 23 - 38
12345